Two Sigma Securities’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,162
Closed -$33.2K – 1791
2026
Q1
$33.2K Sell
3,162
-493
-13% -$4.81K ﹤0.01% 1311
2025
Q4
$42K Buy
+3,655
New +$56.5K 0.01% 1095
2025
Q3
– Sell
-10,154
Closed -$167K – 1455
2025
Q2
$167K Buy
+10,154
New +$175K 0.02% 975
2020
Q1
– Sell
-325
Closed -$205K – 1454
2019
Q4
$205K Buy
+325
New +$159K ﹤0.01% 2078

Other funds holding CDLX

Two Sigma Securities's CDLX Position: Q2 2026 in Review

Two Sigma Securities sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 3,162 shares — an estimated $33.2K sold.

Two Sigma Securities first reported a position in CDLX in Q4 2019 and held it in 4 quarters. The position peaked at $205K in Q4 2019. 43 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Two Sigma Securities reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 3,162 Cardlytics shares in Q2 2026, an estimated $33.2K.
  • Two Sigma Securities first reported a position in Cardlytics in Q4 2019 and held it in 4 quarters.
  • Two Sigma Securities's Cardlytics position peaked at $205K in Q4 2019.
  • 43 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.